Emil T. Kuriakose
Corporate Officer/Principal bij TERNS PHARMACEUTICALS, INC.
Vermogen: 353 121 $ op 31-05-2024
Actieve functies van Emil T. Kuriakose
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2023 | - |
Loopbaan van Emil T. Kuriakose
Eerdere bekende functies van Emil T. Kuriakose
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-07-2013 | 01-01-2016 |
| CALITHERA BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2017 | - |
Opleiding van Emil T. Kuriakose
| Stony Brook University School of Medicine | Doctorate Degree |
| New York University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Beurs
- Insiders
- Emil T. Kuriakose
- Ervaring
